Related Experiment Videos
Summary
Elderly patients require careful dosing of phenytoin (an anticonvulsant). Doses below 300 mg/day are unlikely to reach toxic levels, while 350 mg/day or more may cause dangerous serum concentrations.
Area of Science:
- Pharmacology
- Geriatric Medicine
- Clinical Pharmacy
Background:
- Phenytoin is a widely used anticonvulsant medication.
- Age-related changes can affect drug metabolism and pharmacokinetics.
- Optimal phenytoin dosing in elderly patients requires further investigation.
Purpose of the Study:
- To determine appropriate phenytoin dosage ranges for elderly patients.
- To assess the pharmacokinetic parameters (Vmax and Km) of phenytoin in the elderly.
- To evaluate the implications for anticonvulsant therapy in geriatric populations.
Main Methods:
- Serum phenytoin concentrations were measured in 17 elderly patients.
- Dosage-response relationships were analyzed.
- Mean Vmax and Km values were determined and compared to younger populations.
Main Results:
- Daily doses below 300 mg/day did not result in serum concentrations of 40 mumol/l or higher.
- Doses of 350 mg/day or more led to elevated and potentially toxic serum phenytoin levels.
- Phenytoin Vmax and Km values in elderly patients were similar to those in younger individuals.
Conclusions:
- Phenytoin dosing in the elderly necessitates careful titration to avoid toxicity.
- Lower daily doses may be sufficient for therapeutic effect in older adults.
- Pharmacokinetic parameters for phenytoin do not appear significantly altered by age, suggesting dose adjustments are key.